Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assement of the Morphological Characteristics of the Hips and Correlating Them With the Pathology Found

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03768895
Recruitment Status : Completed
First Posted : December 7, 2018
Last Update Posted : February 19, 2019
Sponsor:
Information provided by (Responsible Party):
Maria Pilar López Royo, Universidad de Zaragoza

Brief Summary:

The investigators' objective is the anatomical analysis of hips studied through MRI, assessing their morphological characteristics and correlating them with the pathology found.

A retrospective search was performed using a database of consecutive reports of 137 adults pelvis MRI examinations obtained at MRI center in Zaragoza.

In all the images the investigators are going to measure the ischiofemoral space, quadratus femoris space, cervicodiaphysal angle and femoral version angle. The investigators evaluated different qualitative changes in the signal intensity of the quadratus femoris muscle as normal, edema, fatty infiltration or atrophy, and of the gluteus muscles as tendinopathy or atrophy, too.


Condition or disease Intervention/treatment
Hip Pain Chronic Musculoskeletal Disease Femoral Anteversion Radiation: MRI

Detailed Description:

The investigators' objective is the anatomical analysis of hips studied through MRI, assessing their morphological characteristics and correlating them with the pathology found.

A retrospective search was performed using a database of consecutive reports of 137 adults pelvis MRI examinations obtained at MRI center in Zaragoza.

The investigators create a protocol for a retrospective review study, with the aim of analysis all the recorded MRI findings during this time. The criteria for patient inclusion were: Age > 18 years old, who had realised a pelvis MRI for any cause at MRI Center. Exclusion criteria included age < 18 years old, inadequate imaging quality, medical history likely to affect pelvic and hip morphometry: pelvic oncological disease, infection or inflammatory arthritis, postsurgical change disruptions, soft tissue abnormality, avascular necrosis, or pelvic and hip fracture.

In all the images the investigators are going to measure the ischiofemoral space, quadratus femoris space, cervicodiaphysal angle and femoral version angle. The investigators evaluated different qualitative changes in the signal intensity of the quadratus femoris muscle as normal, edema, fatty infiltration or atrophy, and of the gluteus muscles as tendinopathy or atrophy, too.


Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 70 participants
Observational Model: Cohort
Time Perspective: Other
Target Follow-Up Duration: 2 Years
Official Title: Assement of the Morphological Characteristics of the Hips and Correlating Them With the Pathology Found
Actual Study Start Date : December 20, 2018
Actual Primary Completion Date : December 30, 2018
Actual Study Completion Date : December 30, 2018

Group/Cohort Intervention/treatment
MRI group
The criteria for patient inclusion were: Age > 18 years old, who had realised a pelvis MRI for any cause at MRI Center. Exclusion criteria included age < 18 years old, inadequate imaging quality, medical history likely to affect pelvic and hip morphometry: pelvic oncological disease, infection or inflammatory arthritis, postsurgical change disruptions, soft tissue abnormality, avascular necrosis, or pelvic and hip fracture.
Radiation: MRI

The technique used was coronal and axial T1 and T2*WI sequences of the pelvis and femurs.

The MRI machine used is a HITACHI AIRIS-II1 model, with permanent vertical magnetic field of 0.3 Tesla, and the used sequences areT1, T2*WI.





Primary Outcome Measures :
  1. Ischiofemoral Space [ Time Frame: 1 day ]
    the smallest distance between the lateral cortex of the ischial tuberosity and medial cortex of the lesser trochanter.

  2. Quadratus Femoris Space [ Time Frame: 1 day ]
    the smallest space for passage of the quadratus femoris muscle delimited by the superolateral surface of the hamstring tendons and the posteromedial surface of the iliopsoas tendón or lesser trochanter.

  3. Cervicodiaphyseal angle [ Time Frame: 1 day ]
    The cervicodiaphyseal angle is formed by the axis of the femoral neck that joins the femoral head with the axis of the femoral shaft.

  4. Femoral version [ Time Frame: 1 day ]
    The femoral version or femoral torsion angle is called the projection on the transverse plane of a longitudinal axis of the femoral neck at the center of the femoral head



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
People who had realised a pelvis MRI for any cause at MRI Center in Zaragoza.
Criteria

Inclusion Criteria:

  • Age > 18 years old

Exclusion Criteria:

  • Age < 18 years old
  • Inadequate imaging quality
  • Medical history likely to affect pelvic and hip morphometry: pelvic oncological disease, infection or inflammatory arthritis, postsurgical change disruptions, soft tissue abnormality, avascular necrosis, or pelvic and hip fracture.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03768895


Locations
Layout table for location information
Spain
Dra. Roca Diagnóstico Médico. CEMEDI
Zaragoza, Spain, 50006
Sponsors and Collaborators
Universidad de Zaragoza

Additional Information:

Layout table for additonal information
Responsible Party: Maria Pilar López Royo, Principal Investigator, Universidad de Zaragoza
ClinicalTrials.gov Identifier: NCT03768895     History of Changes
Other Study ID Numbers: MRI center
First Posted: December 7, 2018    Key Record Dates
Last Update Posted: February 19, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Musculoskeletal Diseases